In a way, it was easier to make a case for MIRI back when they did a lot of advocacy work. Now that they’re billing themselves as a research institute, I think they’ve set a much higher bar for themselves, and when it comes to doing research (as opposed to advocacy) they’ve got much less of a track record to go on.
To put this in context, the emerging consensus is that publicly advocating for x risk reduction in the area of AI is counterproductive, and it is better to network with researchers directly, something that may be best done by performing relevant research.
To put this in context, the emerging consensus is that publicly advocating for x risk reduction in the area of AI is counterproductive, and it is better to network with researchers directly, something that may be best done by performing relevant research.